These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9309754)

  • 1. Successful management of an infected implantable cardioverter defibrillator with oral antibiotics and without removal of the device.
    Turkisher V; Priel I; Dan M
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2268-70. PubMed ID: 9309754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campylobacter fetus infection of an internal cardioverter defibrillator.
    Ahmar W; Johnson D; Richards M; Strathmore N
    Pacing Clin Electrophysiol; 2008 Feb; 31(2):258-9. PubMed ID: 18233985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of an implantable cardioverter defibrillator: management without removal of the device in selected cases.
    Taylor RL; Cohen DJ; Widman LE; Chilton RJ; O'Rourke RA
    Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 1):1352-5. PubMed ID: 1701884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound complications and treatment of the infected implantable cardioverter defibrillator generator.
    Gupta S; Prevel CD; Shaheen K; Wilkens E; Smith DJ; Kirsh MM; Bolling SF; Rees RS
    J Card Surg; 1993 Nov; 8(6):671-7. PubMed ID: 8286873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
    Aboltins CA; Page MA; Buising KL; Jenney AW; Daffy JR; Choong PF; Stanley PA
    Clin Microbiol Infect; 2007 Jun; 13(6):586-91. PubMed ID: 17331125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin.
    Drancourt M; Stein A; Argenson JN; Roiron R; Groulier P; Raoult D
    J Antimicrob Chemother; 1997 Feb; 39(2):235-40. PubMed ID: 9069545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of patients with infected implantable cardioverter-defibrillator systems.
    O'Nunain S; Perez I; Roelke M; Osswald S; McGovern BA; Brooks DR; Torchiana DF; Vlahakes GJ; Ruskin J; Garan H
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):121-9. PubMed ID: 9011681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.
    Fernandes P
    Cold Spring Harb Perspect Med; 2016 Jan; 6(1):a025437. PubMed ID: 26729758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloxacillin and sodium fusidate in management of shunt infections.
    Rao R; Webster AB; Sunderland DR; Smith WF; Ampalam S; Lee HA
    Br Med J; 1972 Sep; 3(5827):618-9. PubMed ID: 5071699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusidic acid in orthopaedic infections due to coagulase-negative staphylococci.
    Coombs RR; Menday AP
    Curr Med Res Opin; 1985; 9(9):587-90. PubMed ID: 3902374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices.
    Molina JE
    Ann Thorac Surg; 1997 Feb; 63(2):504-9. PubMed ID: 9033328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
    Aubin GG; Bémer P; Guillouzouic A; Launay E; Geffroy L; Touchais S; Corvec S
    Infect Dis (Lond); 2016 Sep; 48(9):699-702. PubMed ID: 27194514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of complete system removal of infected cardioverter-defibrillators.
    Mull DH; Wait MA; Page RL; Jessen ME
    Ann Thorac Surg; 1995 Sep; 60(3):704-6. PubMed ID: 7677511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci.
    Guirao-Arrabal E; León-Ruíz L; Pérez-Sola MJ; Carrillo-Alascio PL
    Rev Esp Quimioter; 2016 Apr; 29(2):107-8. PubMed ID: 26888341
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
    de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
    J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.